Filters

Brivaracetam manufacturers

Filters

3 products found

brivaracetam

Tablets 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref. Briviact
Manufacturer #269

A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 8 days

brivaracetam

Oral solution 10 mg/ml - 300 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
CTD with BE with Briviact
Manufacturer #10620

A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, the Middle East, North America, LATAM, and Asia for 50+ years. The main therapeutic areas include cardiovascular, rheumatology, nephrology, and central nervous system. The main dosage forms are oral solid and multi-dose powder. They are produced in GMP-compliant manufacture.

Manufacturer usually replies in 5 days

brivaracetam

Tablets, film coated 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Bulgaria , Czech Republic , Estonia , France , Germany , Hungary , Italy , Latvia , Lithuania , Mexico , Poland , Romania , Slovakia , Sweden , United Kingdom
Comments
Indication: epilepsy
Manufacturer #8070
A pharmaceutical manufacturer that develops, produces and markets both branded medicines and generics, with a focus on treatments for serious and chronic diseases. The company emphasises partnerships, licensing opportunities and specialist indication areas, supporting the global supply of pharmaceutical products via its research & development and manufacturing capabilities.

Manufacturer usually replies in 24 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.